Home › Linfoma a cellule B › Pennsylvania › Philadelphia
Studi clinici su Linfoma a cellule B a Philadelphia, PA
11 studi su Linfoma a cellule B cercano partecipanti presso sedi a Philadelphia e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
In reclutamentoStudio osservazionale
- Children's Hospital of Philadelphia, Philadelphia
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
In reclutamentoFase 1
- University of Pennsylvania Abramson Cancer Center, Philadelphia
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
In reclutamentoFase 1
- Children's Hospital of Philadelphia, Philadelphia
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
In reclutamentoFase 2
- Research Site, Philadelphia
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
In reclutamentoFase 1/2
- Fox Chase Cancer Center, Philadelphia
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
In reclutamentoFase 1/2
- Research Site, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
In reclutamentoFase 1/2
- Thomas Jefferson University, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
In reclutamentoFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CD45BE-HSPC + CART-45 Cells
In reclutamentoFase 1
- University of Pennsylvania, Philadelphia
SynKIR-310 for Relapsed/Refractory B-NHL
In reclutamentoFase 1
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
In reclutamentoFase 1
- Children's Hospital of Philadelphia, Philadelphia
Studi su Linfoma a cellule B in altre città
- New York City, NY19 studi
- Houston, TX16 studi
- Chicago, IL12 studi
- Nashville, TN11 studi
- Rochester, MN10 studi
- Baldwin Park, CA9 studi
- Milwaukee, WI9 studi
- Cleveland, OH9 studi
- Salt Lake City, UT8 studi
- Boston, MA8 studi
- Pittsburgh, PA7 studi
- Columbus, OH7 studi
Altri studi a Philadelphia
- Cancro (tutti i tipi)59 studi
- Cancro al seno56 studi
- Cancro del polmone non a piccole cellule51 studi
- Cancro metastatico46 studi
- Cancro colorettale44 studi
- Cancro ovarico44 studi
- Cancro alla prostata44 studi
- Cancro ai polmoni36 studi
- Leucemia mieloide acuta34 studi
- Insufficienza cardiaca31 studi
- Cancro dell'endometrio28 studi
- Depressione26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.